• M. Oehmichen


Generell ist festzustellen, dass vorsätzliche Vergiftungen durch dritte Hand heute eher selten sind und - auch in den rechtsmedizinischen Instituten - eine Rarität darstellen. Sie wurden in den letzten Jahren vor allem im Zusammenhang mit Giftbeibringung bei alten, hilflosen Patienten beobachtet, zum Teil offenbar um den Sterbeprozess zu verkürzen (aktive Sterbehilfe), zum Teil aus finanziellen Gründen (Oehmichen 1996; Oehmichen u. Meissner 2000). Die Mehrzahl der Vergiftungen bei Kindern erfolgt ferner im Sinne eines Unfallgeschehens, durch Umwelt oder iatrogene Überdosierung mit Medikamenten vor allem bei Kindern (Kruse u. Oehmichen 1994); im Vordergrund der gesellschaftlichen Diskussion stehen jedoch die Drogenintoxikationen bei Jugendlichen.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Adams J H, Haller L, Boa F Y, Doua F, Dago A, Konian K (1986) Human African trypanosomiasis (T. b. gambiense): a study of 16 fatal cases of sleeping sickness with some observations on acute reactive arsenical encephalopathy. Neuropathol Appl Neurobiol 12: 81–94PubMedGoogle Scholar
  2. Alajouanine TH, Dérobert L, Thieffry S (1958) Etude clinique d’ensemble de 210 cas d’intoxication par les sels organiques detain. Rev Neurol 98: 85–96PubMedGoogle Scholar
  3. Alfrey A C, LeGendre G R, Kaehny W D (1976) The dialysis encephalopathy syndrome. Possible aluminium intoxication. N Engl J Med 294: 184–188Google Scholar
  4. Alpers B J, Lewy F H (1940) Changes in the nervous system following carbon-disulfide poisoning in animals and in man. Arch Neurol Psychiatr 44: 725–739Google Scholar
  5. Anderson S N, Skullerud K (1999) Hypoxic/ischaemic brain damage, especially pallidal lesions, in heroin addicts. Forensic Sci Int 102: 51–59Google Scholar
  6. Baker AB (1958) The nervous system in trichlorethylene. J Neuropathol Exp Neurol 17: 649–655PubMedGoogle Scholar
  7. Bakir F, Damluji S, Amin-Zaki L, Murtadha M etal. (1973) Methylmercury poisoning in Iraq. Science 181: 230–241PubMedGoogle Scholar
  8. Balentine J D (ed) (1982) Pathology of oxygen toxicity. Academic Press, New YorkGoogle Scholar
  9. Bank W J (1980) Thallium. In: Spencer P S, Schaumburg H H (eds) Experimental and clinical neurotoxicology. Williams amp; Wilkins, Baltimore, pp 570–577Google Scholar
  10. Bano Y, Hasan M (1989) Mercury induced time-dependent alterations in lipid profiles and lipid peroxidation in different body organs of cat-fish Heteropneustes fossilis. J Environ Sci Health B 24: 145–166PubMedGoogle Scholar
  11. Barbeau A, Inoue N, Cloutier T (1976) Role of manganese in dystonia. In: Eldridge R, Fahn S (eds) Advances in neurology, vol 14. Raven, New York, pp 339–352Google Scholar
  12. Baumgarten H G, Zimmermann B (1992) Cellular and subcellular targets of neurotoxins: the concept of selective vulnerability. In: Herken H, Hucho F (eds) Selective neurotoxicity. Springer, Berlin Heidelberg New York Tokyo, pp 1–27Google Scholar
  13. Bernheimer H, Birkmayer W, Hornykiewicz O etal. (1973) Brain dopamine and the snydromes of Parkinson and Huntington: Clinical, morphological and neurochemical correlations. J Neurol Sei 20: 415–455Google Scholar
  14. Bersch W, Meinhof U, Ule G, Beriet H, Thiess A M (1974) Pathomorphologische und pathochemische Befunde bei akuter H2S-Vergiftung. Verh Dtsch Ges Pathol 58: 502PubMedGoogle Scholar
  15. Besser R, Krämer G, Thümler R, Bohl J, Gutmann L, Hopf H C (1987) Acute trimethyltin limbic-cerebellar syndrome. Neurology 37: 945–950PubMedGoogle Scholar
  16. Bin O H, Garfinkel D (1994) The cadmium toxicity hypothesis of aging: A possible explanation for the zinc deficiency hypotheses of aging. Med Hypotheses 42: 380–384PubMedGoogle Scholar
  17. Bizzi A, Crane R C, Autilio-Gambetti L, Gambetti P (1984) Aluminium effect on slow axonal transport: a novel impairment of neurofilament transport. J Neurosci 4: 722–731PubMedGoogle Scholar
  18. Bonilla E, Diez-Ewald M (1974) Effect of 1-DOPA on brain concentration of dopamine and homovanillic acid in rats after chronic manganese chloride administration. J Neurochem 22: 297–299PubMedGoogle Scholar
  19. Bour H, Ledingham I (eds) (1967) Carbon monoxide poisoning. Elsevier, AmsterdamGoogle Scholar
  20. Brucher JM (1966) Neuropathological problems posed by carbon monoxide poisoning and anoxia. Progr Brain Res 24: 75–100Google Scholar
  21. Bulpitt K H, Verity M A, Clements P H, Paulus A G (1990) Association of L-tryptophan and an illness resembling eosinophilic fascilities. Arth Rheum 33: 918–929Google Scholar
  22. Carpenter S (1990) The human neuropathology of encephalopathic mussel toxin poisoning. Can Dis Weekly Rep 16: 73–74Google Scholar
  23. Cavanagh J B (1979) The „dying back“ process. A common denominator in many naturally occurring and toxic neuropathies. Arch Pathol Lab Med 103: 659–664PubMedGoogle Scholar
  24. Cavanagh J B, Chen F C- K (1971) Amino acid incorporation in protein during the „silent phase“ before organo-mercury and b-bromo-phenylacetylurea neuropathy in the rat. Acta Neuropathol 19: 216–224Google Scholar
  25. Cavanagh J B, Fuller N H, Johnson H R M, Rudge P (1974) The effects of thallium salts, with particular reference to the nervous system changes. Quart J Med 43: 293–319PubMedGoogle Scholar
  26. Ceccarelli B, Clementi F (eds) (1979) Neurotoxins: tools in neurobiology. Raven, New YorkGoogle Scholar
  27. Cendes F, Andermann F, Carpenter S etal. (1995) Temporal lobe epilepsy caused by domoic acid intoxication: Evidence for glutamate receptor-mediated excitotoxicity in humans. Ann Neurol 37: 123–126Google Scholar
  28. Chan S Y, Worth R, Ochs S (1980) Block of axoplasmic transport in vitro by vinca alkaloids. J Neurobiol 11: 251–264PubMedGoogle Scholar
  29. Chang L W (1980) Mercury. In: Spencer P S, Schaumburg H H (eds) Experimental and clinical neurotoxicology. Williams amp; Wilkins, Baltimore, pp 508–526Google Scholar
  30. Cossa P etal. (1958) Encephalopathies toxiques au Stalinon. Aspects anatomicliniques et electroencephalographiques. Rev Neurol 98: 97–108PubMedGoogle Scholar
  31. Crapper McLachlan D R, De Boni U (1980) Aluminium in human brain disease - an overview. Neurotoxicology 1: 3–16Google Scholar
  32. Crapper McLachlan D R, Farnell B, Galin H, Karlik S, Eichhorn G, De Boni U (1983) Aluminium in human brain disease. In: Sarkar B (ed) Biological aspects of metals and metal-related diseases. Raven, New York, pp 209–225Google Scholar
  33. Dam M (1972) The density and ultrastructure of Purkinje cells following diphenylhydantoin treatment in animals and man. Acta Neurol Scand Suppl 49: 3–65PubMedGoogle Scholar
  34. Dempsey G, Meitzer H L (1977) Lithium toxicity: a review. In: Roizin L, Shiraki H, Grcevic N (eds) Neurotoxicology, vol 1. Raven, New York, pp 171–203Google Scholar
  35. Diemer N H (1976) Number of Purkinje cells and Bergmann astrocytes in rats with CCl4-induced liver disease. Acta Neurol Scand 55: 1–15Google Scholar
  36. Doctor S V, Fox D A (1983) Immediate and long-term alterations in maximal electroshock seizure responsiveness in rats neonatally exposed to triethylin bromide. Toxicol Appl Pharmacol 68: 268–281PubMedGoogle Scholar
  37. Dolly J O (1992) Peptide toxins that alter neurotransmitter release. In: Herken H, Hucho F (eds) Selective neurotoxicity. Springer, Berlin Heidelberg New York Tokyo, pp 681–717Google Scholar
  38. Dominiak P (1992) Zur Pharmakologie von Suchtstoffen. Amphetamin, Cocain, Cannabis und Heroin. In: Oehmichen M, Pätzold D, Birkholz M (Hrsg) Drogenabhängigkeit. Schmidt-Römhild, Lübeck, S 67–90Google Scholar
  39. Donofrio P D, Wilbourn A J, Albers J W, Rogers L, Salanga V and Greenberg HS (1987) Acute arsenic intoxication presenting as Guillain-Barre-like syndrome. Muscle Nerve 10: 114–120PubMedGoogle Scholar
  40. Drenckhahn D, Lüllmann-Rauch R (1979) Drug-induced experimental lipidosis in the nervous system. Neuroscience 4: 697–712PubMedGoogle Scholar
  41. Duckett S, White R (1974) Cerebral lipofuscinosis induced with tellurium: electron dispersive x-ray spectrophotometry analysis. Brain Res 73: 205–214PubMedGoogle Scholar
  42. Elliott H L, Dryburgh F, Fell S, Sabet S, Mac Dougall A I (1978) Aluminium toxicity during regular haemodialysis. BMJ 1: 1101–1103Google Scholar
  43. Erlanson P, Fritz H, Hagstam K E etal. (1965) Severe methanol intoxication. Acta Med Scand 177: 393–408PubMedGoogle Scholar
  44. Ernst A, Zibrak J D (1998) Carbon monoxide poisoning. New Engl J Med 339: 1603–1608PubMedGoogle Scholar
  45. Escourolle R, Bourdon R, Galli A, Galle P, Jaudon M C, Hauw J J, Gray F (1977) Etude neuropathologique et toxicologique de douze cas d’encephalopathie bismuthique ( EB ). Rev Neurol 133: 153–163PubMedGoogle Scholar
  46. Eto K, Takeuchi T (1978) A pathological study of prolonged cases of minamata disease. Acta Pathol Jap 28: 565–584Google Scholar
  47. Fam A G, Gordon D A, Sarkozi J etal. (1984) Neurologic complications associated with gold therapy for rheumatoid arthritis. J Rheumatol 11: 700–706PubMedGoogle Scholar
  48. Feun L G, Wallace S, Stewart D J etal. (1984) Intracarotid infusion of cis-diaminedichloroplatinum in the treatment of recurrent malignant brain tumours. Cancer 54: 794–799PubMedGoogle Scholar
  49. Filley C M (1999) Toxic leukoencephalopathy. Clin Neuropharmacol 22: 249–260PubMedGoogle Scholar
  50. Fisher C M and Adams R D (1956) Diphtheritic polyneuritis - a pathological study. J Neuropathol Exp Neurol 15: 243–268PubMedGoogle Scholar
  51. Flammer R (1980) Differentialdiagnose der Pilzvergiftungen. Fischer, StuttgartGoogle Scholar
  52. Freedman M S, Schneiderman J H, Turley J, DePetrillo A D Neurologic complications following intra-arterial cisplatinum chemotherapy. Can J Neurol Sci 14: 325–327Google Scholar
  53. Frisch S, Keweloh T, Beiz H-H, Kijewski H (1997) Untersuchung zur Einwanderung von organischen Verbindungen in Keratin und deren Konsequenzen für den Nachweis von Drogen und organischen Giften in Haaren. In: Kijewski H (Hrsg) Das Haar als Spur. Schmidt-Römhild, Lübeck (Research in legal medicine, vol 16 ) pp 13–29Google Scholar
  54. Gabbiani G, Gregory A, Baie D (1967) Cadmium-induced selective lesions of sensory ganglia. J Neuropathol Exp Neurol 26: 498–506PubMedGoogle Scholar
  55. Geldmacher v. Mallinckrodt M (1975) Forensische Toxikologie. In: Mueller B (Hrsg) Gerichtliche Medizin, Bd 2. Springer, Berlin Heidelberg New York, S 691–988Google Scholar
  56. Geschwinde T (1998) Rauschdrogen. Marktformen und Wirkungsweisen. Springer, Berlin Heidelberg New York TokyoGoogle Scholar
  57. Gherardi R K, Chariot T, Vanderstigel F etal. (1990) Organic arsenic-induced Gullain-Barré-like syndrome due to melarsoprol: A clinical, electrophysicological study. Muscle Nerve 13: 637–645PubMedGoogle Scholar
  58. Grundt I K, Bakken A M (1986) Adenine nucleotides in cultered brain cells after exposure to methyl mercury and triethyl lead. Acta Pharmacol Toxicol 59: 11–16Google Scholar
  59. Gruner J E (1958) Lésions du névraxe secondaires à l’ingestion d’éthyl-étain (Stalinon). Rev Neurol 98: 109–116PubMedGoogle Scholar
  60. Hargreaves R J, Evans J G, Janota I, Magos L, Cavanagh J B Persistent mercury in nerve cells 16 years after metallic mercury poisoning. Neuropathol Appl Neurobiol 14: 443–452Google Scholar
  61. Haschek W M, Rousseaux C G (1998) Fundamentals of toxicologic pathology. Academic Press, San DiegoGoogle Scholar
  62. Henze T, Scheidt P, Prange H W (1986) Methanol poisoning. Clinical, neuropathologic and computerized tomography findings. Nervenarzt 57: 658–661PubMedGoogle Scholar
  63. Herken H, Hucho F (1992) Selective neurotoxicity. Springer, Berlin Heidelberg New York TokyoGoogle Scholar
  64. Herndon R M (1968) Thiophen induced granule cell necrosis in the rat cerebellum. An electron microscopic study. Exp Brain Res 6: 49–68PubMedGoogle Scholar
  65. Hörtnagel H, Hanin J (1992) Toxic affecting the cholinergic system. In: Herken H, Hucho F (eds) Selective neurotoxicity. Springer, Berlin Heidelberg New York Tokyo, pp 293–332Google Scholar
  66. Hurst E W (1959) The lesions produced in the central nervous system by certain organic arsenical compounds. J Pathol Bacteriol 77: 523–534PubMedGoogle Scholar
  67. Jin T, Lu J, Nordberg M (1998) Toxicokinetics and biochemistry of cadmium with special emphasis on the role of metallothionein. Neurotoxicology 19: 529–535PubMedGoogle Scholar
  68. Johansson B B (1992) Protective barriers in the nervous system against neurotoxic agents: the blood-brain barrier. In: Herken H, Hucho F (eds) Selective neurotoxicity. Springer, Berlin Heidelberg New York Tokyo, pp 67–80Google Scholar
  69. Juntunen H, Hernberg S, Eistola P, Hupli V (1980) Exposure to industrial solvents and brain atrophy. Eur Neurol 19: 366–375Google Scholar
  70. Kaelan C, Harper C, Vieira B I (1986) Acute encephalopathy and death due to petrol sniffing: Neuropathological findings. Aust NZ J Med 16: 804–807Google Scholar
  71. Kaplan J G (1980) Neurotoxicity of selected biological toxins. In: Spencer P S, Schaumburg H H (eds) Experimental and clinical neurotoxicology. Williams amp; Wilkins, Baltimore, pp 631–648Google Scholar
  72. Kennedy P, Cavanagh J B (1976) Spinal changes in the neuropathy of thallium poisoning. J Neurol Sci 29: 295–301PubMedGoogle Scholar
  73. Kesson C M, Baird A W, Lawson D H (1977) Acrylamide poisoning. Postgrad Med J 53: 16–17Google Scholar
  74. Kim Y H, Foo M, Terry R D (1982) Cyanide encephalopathy following therapy with sodium nitroprusside. Arch Pathol Lab Med 106: 392–393Google Scholar
  75. Kishorekumar R, Yagnik P, Dhopesh V (1985) Acute myelopathy in a drug abuser following an attempted neck vein injection. J Neurol Neurosurg Psychiatry 48: 843–844PubMedGoogle Scholar
  76. Klatzo J (1977) Pathologic aspects of the blood-brain barrier. In: Roizin L, Shiraki H, Grcevic N (eds) Neurotoxicology. Raven, New York, pp 577–584Google Scholar
  77. Klatzo I, Wisniewski H, Streicher E (1965) Experimental production of neurofibrillary degeneration. I. Light microscopic observations. J Neuropathol Exp Neurol 24: 187–199Google Scholar
  78. Klinghard G W (1976) Lysosomen bei experimenteller Speicherdystrophie durch chronische Intoxikation mit Chlorochin. Verh Dtsch Ges Pathol 60: 229–232Google Scholar
  79. Koestner A, Norton S (1991) Nervous system. In: Haschek W M, Rousseaux C G (eds) Handbook of toxicologic pathology. Academic Press, San Diego, pp 625–674Google Scholar
  80. Kolkmann F W, Volk B (1976) Über Körnerzellnekrosen bei der experimentellen Methylchloridvergiftung des Meerschweinchens. Exp Pathol 10: 298–308Google Scholar
  81. Kornfeld M, Moser A B, Moser H W etal. (1994) Solvent vapor abuse leukoencephalopathy. Comparison to adenoleukodystrophy. J Neuropathol Exp Neurol 53: 389–398Google Scholar
  82. Kriegelstein J, Kuglisch J (1992) Metabolic disorders as consequences of drug-induced energy deficits. In: Herken H, Hucho F (eds) Selective neurotoxicology. Springer, Berlin Heidelberg New York Tokyo, pp 111–139Google Scholar
  83. Kruse K, Oehmichen M (eds) (1994) Vergiftungen im Kindesalter. Hansisches Verlagskontor, LübeckGoogle Scholar
  84. Lampert P, Garro F, Pentschew A (1970) Tellurium neuropathy. Acta Neuropathol 15: 308–317Google Scholar
  85. Lawrence W H, Partyka E K (1981) Chronic dysphagia and trigeminal anesthesia after trichloroethylene exposure. Ann Intern Med 95: 710Google Scholar
  86. Le Quesne P M, McLeod J G (1977) Peripheral neuropathy following a single exposure to arsenic. Clinical course in four patients with electrophysiological and histological studies. J Neurol Sci 32: 437–451Google Scholar
  87. Levine S R, Brust J C M, Futrell N etal. (1991) A comparative study of the cerebrovascular complications of cocaine: Alkaloidal versus hydrochloride - a review. Neurology 41: 1173–1177Google Scholar
  88. Liessens JL, Monstrey J, Vanden-Eeckhout E, Djudzman R, Martin J J (1978) Bismuth encephalopathy. A clinical and anatomopathological report of one case. Acta Neurol Belg 78: 301–309PubMedGoogle Scholar
  89. Lock E A, Aldridge W N (1975) The binding of triethyltin to rat brain myelin. J Neurochem 25: 871–876PubMedGoogle Scholar
  90. Ludwig G D ( 1977 a) Lead poisoning. In: Goldensohn E S, Appel SH (eds) Scientific approaches to clinical neurology. Lea amp; Febiger, Philadelphia, pp 1347–1373Google Scholar
  91. Ludwig G D ( 1977 b) Mercury poisoning. In: Goldensohn E S, Appel S H (eds) Scientific approaches to clinical neurology. Lea amp; Febiger, Philadelphia, pp 1380–1383Google Scholar
  92. Magos L (1975) Mercury and mercurials. Br Med Bull 31: 241–245PubMedGoogle Scholar
  93. Makrigeorgi-Butera M, Hagel C, Laas R, Piischel K, Stavrou D (1996) Comparative brain pathology of HlV-seronegative and HIV-infected drug addicts. Clin Neuropathol 15: 324–329PubMedGoogle Scholar
  94. Malm G, Lying-Tunell U (1980) Cerebellar dysfunction related to toluene sniffing. Acta Neurol Scand 62: 188–190PubMedGoogle Scholar
  95. Mamoli B, Thaler A, Heilig P, Siakos G (1975) Subakute Myelo-Optico-Neuropathie ( S.M.O.N.) nach Clioquinolmedikation. J Neurol 209: 139–147Google Scholar
  96. Marinez A J, Boehm R, Hadfield M G (1974) Acute hexachlorphene encephalopathy: Clinico-neuropathological correlation. Acta Neuropathol 28: 93–103Google Scholar
  97. Marsh D O, Myers G J, Clarkson TW, Amin-Zaki L, Tikriti S, Majeed M A (1980) Fetal methylmercury poisoning: clinical and toxicological data on 29 cases. Ann Neurol 7: 348–353PubMedGoogle Scholar
  98. Martyn C N, Barker L J P, Osmond C, Harris E C, Edwardson J A, Lacy R F (1989) Geographical relationship between Alzheimer’s disease and aluminium in drinking water. Lancet I: 59–62Google Scholar
  99. McDermott J R, Smith A I, Ward M K, Parkinson I S, Kerr D N S (1978) Brain-aluminium concentration in dialysis encephalopathy. Lancet I: 901–904Google Scholar
  100. McLaughlin A I G, Kazantzis G, King E, Teare D, Porter R J, Owen R (1962) Pulmonary fibrosis and encephalopathy associated with the inhalation of aluminium dust. Br J Indust Med 19: 253–263Google Scholar
  101. McLean D R, Jacobs H, Mielke B W (1980) Methanol poisoning. A clinical and pathological study. Ann Neurol 8: 161–167Google Scholar
  102. Melnick R L, Monti L G, Motzkin S M (1976) Uncoupling of mitochondrial oxidative phosphorylation by thallium. Biochem Biophys Res Commun 69: 68–73PubMedGoogle Scholar
  103. Mena I (1979) Manganese poisoning. In: Vinken P J, Bruyn G W (eds) Handbook of clinical neurology, vol. 36. North-Holland, Amsterdam, pp 217–237Google Scholar
  104. Menne FR (1938) Acute methyl alcohol poisoning; report of 22 instances with postmortem examinations. Arch Pathol 26: 77–92Google Scholar
  105. Merigan W H, Weiss B (eds) (1980) Neurotoxicity of the visual system. Raven, New YorkGoogle Scholar
  106. Mody C K, Miller B L, Mclntyre, Cobb S K, Goldberg M A (1988) Neurologic complications of cocaine abuse. Neurology 38: 1189–1193Google Scholar
  107. Moeschlin S (1980) Thallium poisoning. Clin Toxicol 17: 133–146PubMedGoogle Scholar
  108. Muller H A, Jeschke R (1970) Cytologische Befunde an den motorischen Vorderhornganglienzellen beim Tetanus. Verh Dtsch Path Ges 54: 650Google Scholar
  109. Murata J (1971) Chronic entero-osteo-nephropathy due to cadmium („itai-itai“ disease). J Jap Med Assoc 65: 15Google Scholar
  110. Newland M, Ceckler T, Kordower J, Weiss B (1989) Visualizing manganese in the primate basal ganglia with magnetic resonance imaging. Exp Neurol 106: 251–258PubMedGoogle Scholar
  111. Niklowitz W J (1977) Subcellular mechanisms in lead toxicity: significance in childhood encephalopathy, neurological requelae and late dementias. In: Roizin L, Shiraki M, Grcevic N (eds) Neurotoxicology. Raven, New York, pp 289–298Google Scholar
  112. Niklowitz W J, Mandybur T I (1975) Neurofibrillary changes following childhood lead encephalopathy. J Neuropathol Exp Neurol 34: 445–455PubMedGoogle Scholar
  113. Ochs S (1992) Kinetic and metabolic disorders of axoplasmic transport induced by neurotoxic agents. In: Herken H, Hucho F (eds) Selective neurotoxicity. Springer, Berlin Heidelberg New York Tokyo, pp 81–110Google Scholar
  114. Oehmichen M (Hrsg) (1996) Lebensverkürzung, Tötung und Serientötung - eine interdisziplinäre Analyse der „Euthanasie“. Schmidt-Römhild, LübeckGoogle Scholar
  115. Oehmichen M (2000) Hyperthermie, Brand und Kohlenmonoxid im rechtsmedizinischen Aufgabenspektrum. In: Oehmichen M (Hrsg) Hyperthermie, Brand und Kohlenmonoxid/Research in Legal Medicine. Schmidt-Römhild, vol 21, Lübeck, pp 15–25Google Scholar
  116. Oehmichen M, Besserer K (1982) Forensic significance of acetylcholine esterase histochemistry in organophosphate intoxication. Z Rechtsmed 89: 149–165PubMedGoogle Scholar
  117. Oehmichen M, Meissner C (2000) Life shortening and physician assistance in dying. Euthanasia from the viewpoint of German Legal Medicine. Gerontology 46: 212–218Google Scholar
  118. Oehmichen M, Schlote W, Mallach M J (1983) Hirnveränderungen bei Parathion-Vergiftung: Beobachtungen in 42 Fällen. Z Rechtsmed 90: 173–189PubMedGoogle Scholar
  119. Oehmichen M, Pedal J, Besserer K, Gencic M (1984) Inhibition of nonspecific esterase activity. Absence of monocyte esterase activity due to phosphoric and thiophosphoric acid ester intoxication. Forensic Sci Int 25: 181–189PubMedGoogle Scholar
  120. Oehmichen M, Meissner C, Reiter A, Birkholz M (1996) Neuropathology in non-human immunodeficiency virus-infected drug addicts: hypoxic brain damage after chronic intravenous drug abuse. Acta Neuropathol 91: 642–646PubMedGoogle Scholar
  121. Oehmichen M, Ochs U, Meissner C (2001) Regional potassium distribution in the brain in forensic relevant types of intoxication. Morphometric evaluation using a histochemical method. Neurotoxicology 22: 99–107Google Scholar
  122. Orthner H (1949) Neuartige Hirnbefunde bei Methyl-Alkohol-Vergiftung. Zentralbf Allg Pathol 85: 11–16Google Scholar
  123. Osetowska E (1971) Gases. In: Minckler J (ed) Pathology of the nervous system. McGraw-Hill, New York, pp 1642–1655Google Scholar
  124. Pankow D (1981) Toxikologie des Kohlenmonoxids. Volk und Gesundheit, BerlinGoogle Scholar
  125. Pankratz M, Solnek M, v. Meyer L (1988) Symmetrische Linsenkernläsionen bei Vergiftungen. In: Bauer G (Hrsg) Festschrift für Wilhelm Holczabek. Deuticke, Wien, S 501–506Google Scholar
  126. Peiffer J (1981) Clinical and neuropathological aspects of long-term damages to the CNS after lithium medication. Arch Psychiatr Nervenkr 231: 41–50PubMedGoogle Scholar
  127. Pentschew A (1965) Morphology and morphogenesis of lead encephalopathy. Acta Neuropathol 5: 133–160PubMedGoogle Scholar
  128. Perl T M, Vedard L, Kosatzsky T etal. (1990) An outbreak of toxic encephalopathy caused by eating mussels contaminated with domoic acid. New Engl J Med 322: 1775–1780PubMedGoogle Scholar
  129. Pery R P, Jacobsen ES (1984) Gold induced encephalopathy: case report. J Rheumatol 11: 233–234Google Scholar
  130. Peters H A, Levine R L, Matthews C G, Chapman L J (1988) Extrapyramidal and other neurologic manifestations associated with carbon disulfide fumigant exposure. Arch Neurol 45: 537–540PubMedGoogle Scholar
  131. Phang P T, Passerini L, Mielke V etal. (1988) Brain hemorrhage associated with methanol poisoning. Crit Care Med 16: 137–140PubMedGoogle Scholar
  132. Philen R M, Posada M (1993) Toxic-oil syndrome and eosinophilia-myalgia syndrome. Semin Arthritis Rheum 23: 104–124PubMedGoogle Scholar
  133. Poulet-Perez E, Maeder P, Rivier L, Deonna T (1992) Toxic leucoencephalopathy after heroin ingestion in a 2-year old child. Lancet 340: 729Google Scholar
  134. Powell H C, Lampert P W (1977) Hexachlorophene neurotoxicity. In: Roizen L, Shiraki H, Grcevic N (eds) Neurotoxicology. Raven, New York, pp 381–389Google Scholar
  135. Powell H, Swarner O, Gluck L, Lampert P (1973) Hexachlorophene myelinopathy in premature infants. J Pediat 82: 976–981PubMedGoogle Scholar
  136. Price D L, Griffin J, Peck K (1975 a) Tetanus toxin: evidence for binding at presynaptic nerve endings. Brain Res 121: 379–384Google Scholar
  137. Price D L, Griffin J, Young A, Peck K, Stoks A (1975 b) Tetanus toxin: direct evidence for retrograde axonal transport. Science 188: 945–947Google Scholar
  138. Provias J P, Ackerley C A, Smith C, Becker L E (1994) Cadmium encephalopathy: A report with elemental analysis and pathological findings. Acta Neuropathol 88: 583–586Google Scholar
  139. Pryor G T (1990) Assessing neurotoxic consequences of solvent abuse: A developing animal model for toluene-induced neurotoxicity. In: Spencer J W, Boren J J (eds) Residual effects of abused drugs on behavior. Rockville/MD (NIDA Research Monograph 101 )Google Scholar
  140. Püschel K (1992) Drogenabhängigkeit aus rechtsmedizinischer Sicht. In: Oehmichen M, Patzelt D, Birkholz M (Hrsg) Drogenabhängigkeit. Schmidt-Römhild, Lübeck (Research in legal medicine, vol 4, pp 23–38 )Google Scholar
  141. Ray R, Prabhu G G, Mohan D, Nath L M, Neki J S (1979) Chronic cannabis use and cognitive functions. Indian J Med Res 69: 996–1000PubMedGoogle Scholar
  142. Recker S (1999) Die Höhe der Morphinkonzentration im Blut von Heroinabhängigen. Inang.-Diss. LübeckGoogle Scholar
  143. Reiter A, Rohwer J, Friedrich H H, Oehmichen M (2001) Time of drug elimination in chronic drug abusers. Forens Sci Ind 119: 248–253Google Scholar
  144. Reusche E, Seydel U (1993) Dialysis associated encephalopathy. Light and electron microscopic morphology and topography with evidence of aluminium by laser microprobe mass analysis. Acta Neuropathol 86: 249–258Google Scholar
  145. Richter RW, Pearson J, Bruun B (1973) Neurological complications of addiction to heroin. Bull NY Acad Med 49: 3–21Google Scholar
  146. Rochholz G, Fischer F, Schütz S, Ritz-Timme S, Kaatsch H-J (1999) Nachweis von Drogen und Medikamenten in humanem Knochengewebe. Rechtsmedizin 9: A84Google Scholar
  147. Rodier J (1955) Manganese poisoning in Moroccan miners. Br J Indust Med 12: 21–35Google Scholar
  148. Rosenberg N L, Stitz M C, Filley C M etal. (1988) Central nervous system effects of chronic toluene abuse - clinical, brain stem evoked response and magnetic resonance imaging studies. Neurotoxicol Teratol 10: 489–495PubMedGoogle Scholar
  149. Ross W D, Emmett E A, Steiner J, Tureen R (1981) Neurotoxic effects of occupational exposure to organotins. Am J Psychiatry 138: 1092–1095PubMedGoogle Scholar
  150. Rubinstein L J, Herman M M, Long T F, Wilbur J R (1975) Disseminated necrotizing leukoencephalopathy: a complication of treated central nervous system leukemia and lymphoma. Cancer 35: 291–305PubMedGoogle Scholar
  151. Sachs H (1997) Drogennachweis in Haaren. In: Kijewski H (Hrsg) Das Haar als Spur. Schmidt-Römhild, Lübeck (Research in legal medicine, vol 16 ) pp 119–133Google Scholar
  152. Saida K, Mendell J R, Sahenk Z (1977) Peripheral nerve changes induced by local application of bee venom. J Neuropathol Exp Neurol 36: 783–796PubMedGoogle Scholar
  153. Sarafian T, Verity MA (1986) Mechanism of apparent transcription inhibition by methylmercury in cerebellar neurons. J Neurochem 47: 625–631PubMedGoogle Scholar
  154. Sasa M, Igarashi S, Miyazaki T, Miyazaki K, Nauno S, Matsuda I (1978) Equilibrium disorders with diffuse brain atrophy in long-term toluene sniffing. Arch Otolaryngol 221: 103–169Google Scholar
  155. Schaumburg H H, Spencer P S (1976) Degeneration in central and peripheral nervous system produced by pure n-hexane: an experimental study. Brain 99: 183–192PubMedGoogle Scholar
  156. Schaumburg H H, Spencer P S (2000) Clioquinol. In: Spencer P S, Schaumburg H H (eds) Experimental and clinical pathology. Oxford University Press, New York OxfordGoogle Scholar
  157. Schmidt G (1946) Zur Klinik der akuten Methylalkoholvergiftung. Dtsch Med Wochenschr 71: 61–64Google Scholar
  158. Scholtz C L, Swash M, Gray A, Kogeorgos J, Marsh F (1987) Neurofibrillary neuronal degeneration in dialysis dementia: a feature of aluminium toxicity. Clin Neuropathol 6: 93–97PubMedGoogle Scholar
  159. Schräder G (1963) Die Entwicklung neuer insektizider Phosphorsäure-Ester. Verlag Chemie, WeinheimGoogle Scholar
  160. Schröder J M (2000) Cadmium. In: Spencer P S, Schaumburg H H (eds) Experimental and chemical neurotoxicology. Oxford University Press, New York Oxford, pp 276–280Google Scholar
  161. Schwedenberg T H (1959) Leukoencephalopathy following carbon monoxide asphyxia. J Neuropathol Exp Neurol 18: 597–608PubMedGoogle Scholar
  162. Shapiro W R, Chernik N L, Posner J B (1973) Necrotizing encephalopathy following intraventricular instillation of methotrexate. Arch Neurol 28: 96–102PubMedGoogle Scholar
  163. Shuman R M, Leech R W, Alvord E C (1973 a) Neurotoxicity of hexachlorophene in human infants: A histopathologic study of 250 infants. Amer J Pathol 70: 19a–20aGoogle Scholar
  164. Shuman R M, Leech R W, Alvord E C, Sumi S M (1973 b) Experimental neurotoxicity of phisophex. J Neuropathol Exp Neurol 33: 195–201Google Scholar
  165. Silbergeld E K (1983) Localization of metals: issues of importance to neurotoxicology of lead. Neurotoxicology 4: 193–200PubMedGoogle Scholar
  166. Slyter H, Liwnicz B, Herrick M K, Mason R (1980) Fatal myelo-encephalopathy caused by intrathecal vincristine. Neurology 30: 867–871PubMedGoogle Scholar
  167. Song SY, Okeda R, Funata N, Higoshino F (1983) An experimental study of the pathogenesis of the selective lesion of the globus pallidus in acute carbon monoxide poisoning in cats. Acta Neuropathol 61: 232–238PubMedGoogle Scholar
  168. Spencer P S, Schaumburg H H (1974) A review of acrylamide neurotoxicity. Part I. Properties, uses and human exposure. Can J Neurol Sci 1: 151–169Google Scholar
  169. Spencer P S, Schaumburg H H (eds) (2000) Experimental and chemical neurotoxicology. Oxford University Press, New York OxfordGoogle Scholar
  170. Stodieck S R G (1983) Querschnittsmyelopathie bei Heroinabhängigkeit. Dtsch Med Wochenschr 108: 235–236Google Scholar
  171. Strong M J, Wolff A B, Wakayama I, Garruto R M (1991) Aluminium-induced chronic myelopathy in rabbits. Neurotoxicology 12: 9–21PubMedGoogle Scholar
  172. Sudo K (1968) Über einen Fall mit ausgedehnten fleckförmigen Entmarkungen als Folge eines protrahierten Ödems nach akuter Morphium Intoxikation. Kyushu Neuropsychiatry 14: 198–206Google Scholar
  173. Takeuchi T, Eto N, Eto K (1979) Neuropathology of childhood cases of methylmercury poisoning ( Minamata disease) with prolonged symptoms, with particular reference to the decortication syndrome. Neurotoxicology 1: 1–20Google Scholar
  174. Thom SR (1990) Carbon monoxide-mediated brain lipid peroxidation in the rat. J Appl Physiol 68: 997–1003PubMedGoogle Scholar
  175. Thom SR (1992) Dehydrogenase conversion to oxidase and lipid peroxidation in brain after carbon monoxide poisoning. J Appl Physiol 73: 1584–1589PubMedGoogle Scholar
  176. Thomas E (1960) Veränderungen des Nervensystems bei Vergiftungen mit niedrigen Halogenkohlenwasserstoffen. Dtsch Z Nervenheilkd 180: 530–561PubMedGoogle Scholar
  177. Thomas P K, Schaumburg H H, Spencer P S, Kaeser H E, Pallis C A, Clifford R F, Wadia N H (1984) Central distal axonopathy syndromes: newly recognized models of naturally occurring human degenerative disease. Ann Neurol 15: 313–315PubMedGoogle Scholar
  178. Tonge J I, Burry A F, Saal J R (1977) Cerebellar calcification: A possible marker of lead poisoning. Pathology 9: 289–300Google Scholar
  179. Tripier M F, Berard M, Toga M, Martin-Bouyer G, Le Breton R, Garat J (1981) Hexachlorophene and the central nervous system. Acta Neuropathol 53: 65–74PubMedGoogle Scholar
  180. Ule G, Pribilla O (1962) Hirnveränderungen nach Cyankalivergiftung mit protrahiertem (intervallärem) klinischen Verlauf. Acta Neuropathol 1: 406–412Google Scholar
  181. Valpey R, Sumi M, Copass M K, Goble G J (1978) Acute and chronic progressive encephalopathy due to gasoline sniffing. Neurology 28: 507–510PubMedGoogle Scholar
  182. Velvart J, Moeschlin S (1980) Insektizide. In: Moeschlin S (Hrsg) Klinik und Therapie der Vergiftungen. Thieme, Stuttgart, S 422–444Google Scholar
  183. Verity M A (1997) Toxic disorders. In: Graham D I, Lantos P I (eds) Greenfield’s neuropathology. Arnold, London, pp 755–797Google Scholar
  184. Verity M A, Brown W J, Cheung M (1975) Organic mercurial encephalopathy: in vivo and in vitro effects of methyl mercury on synaptosomal respiration. J Neurochem 25: 759–766PubMedGoogle Scholar
  185. Vogt C, Vogt O (1937) Sitz und Wesen der Krankheit im Lichte der topistischen Hirnforschung und des Variierens der Tiere. J Psychol Neurol 47: 237–457Google Scholar
  186. Volk B, Kirchgässner N, Detmar M (1986) Degeneration of granule cells following chronic phenytoin administration and electron microscopic investigation of the mouse cerebellum. Exp Neurol 91: 60–70PubMedGoogle Scholar
  187. Vycudilik W (1988) Vergleichende Morphinbestimmungen an Gehirnteilen mittels kombinierter GC/MS. Eine Möglichkeit zur Eingrenzung der Überlebenszeit. Z Rechtsmed 99: 263–272PubMedGoogle Scholar
  188. Wada K, Fujii Y, Watanabe H, Satoh M. Furuichi Y (1991) Cadmium directly acts on endothelin receptor and inhibits endothelin binding acticity. FEBS Lett 285: 71Google Scholar
  189. Walsh T J, Clark A W, Parhad I M, Green W R (1982) Neurotoxic effects of cisplatin therapy. Arch Neurol 39: 719–720PubMedGoogle Scholar
  190. Weinstein L (1974) Diphteria. In: Winthrobe M M, Thorn G W, Adams R D, Braunwald E, Isselbacher K J, Petersdorf R G (eds) Harrison’s principles of internal medicine, 7th edn. McGraw-Hill, New York, pp 841–845Google Scholar
  191. Williams M E, Walker A N, Bracikowski J P etal. (1983) Ascending myeloencephalopathy due to intrathecal vincristine sulfate. Cancer 51: 2041–2047PubMedGoogle Scholar
  192. Wisniewski H M, Sturman J A, Shek J W (1979) Aluminium chloride induced neurofibrillary changes in the developing rabbit: a chronic animal model. Ann Neurol 8: 479–490Google Scholar
  193. Wolters E, Wijngaarden G, Stam F etal. (1982) Leukoencephalopathy after inhaling heroin pyrolysate. Lancet II: 1233–1237Google Scholar
  194. Yamada M, Ohno S, Okayasu I etal. (1986) Chronic manganese poisoning: A neuropathological study with determination of manganese distribution in the brain. Acta Neuropathol (Berlin) 70: 273–278Google Scholar
  195. Zhang J, Piantadosi CA (1992) Mitochondrial oxidative stress after carbon monoxide hypoxia in the rat brain. J Clin Invest 90: 1193–1199PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2002

Authors and Affiliations

  • M. Oehmichen

There are no affiliations available

Personalised recommendations